These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12423245)

  • 21. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.
    Kuroki T; Ichikawa J; Dai J; Meltzer HY
    Brain Res; 1996 Dec; 743(1-2):357-61. PubMed ID: 9017269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze.
    Sakaue M; Ago Y; Sowa C; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2003 Jan; 458(1-2):141-4. PubMed ID: 12498918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats.
    Gobert A; Millan MJ
    Neuropharmacology; 1999 Feb; 38(2):315-7. PubMed ID: 10218874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice.
    Abe M; Nakai H; Tabata R; Saito K; Egawa M
    Jpn J Pharmacol; 1998 Mar; 76(3):297-304. PubMed ID: 9593223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
    Abe M; Tabata R; Saito K; Matsuda T; Baba A; Egawa M
    J Pharmacol Exp Ther; 1996 Aug; 278(2):898-905. PubMed ID: 8768745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
    Lorrain DS; Matuszewich L; Hull EM
    Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by 5-hT2A receptors of aggressive behavior in isolated mice.
    Sakaue M; Ago Y; Sowa C; Sakamoto Y; Nishihara B; Koyama Y; Baba A; Matsuda T
    Jpn J Pharmacol; 2002 May; 89(1):89-92. PubMed ID: 12083749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats.
    Przegaliñski E; Filip M
    Behav Pharmacol; 1997 Dec; 8(8):699-706. PubMed ID: 9832955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA; Theobald DE; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropharmacologic studies on the brain serotonin1A receptor using the selective agonist osemozotan.
    Matsuda T
    Biol Pharm Bull; 2013; 36(12):1871-82. PubMed ID: 24292048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
    Millan MJ; Dekeyne A; Gobert A
    Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.
    Herian M; Wojtas A; Sobocińska MK; Skawski M; González-Marín A; Gołembiowska K
    Pharmacol Rep; 2020 Dec; 72(6):1593-1603. PubMed ID: 33174181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
    Gur E; Lerer B; Newman ME
    J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.
    Kannari K; Yamato H; Shen H; Tomiyama M; Suda T; Matsunaga M
    J Neurochem; 2001 Mar; 76(5):1346-53. PubMed ID: 11238719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity.
    Dalley JW; Theobald DE; Pereira EA; Li PM; Robbins TW
    Psychopharmacology (Berl); 2002 Nov; 164(3):329-40. PubMed ID: 12424557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.
    Ng NK; Lee HS; Wong PT
    J Neurosci Res; 1999 Mar; 55(5):600-7. PubMed ID: 10082082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.